AU2001225380A1 - 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors - Google Patents
2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitorsInfo
- Publication number
- AU2001225380A1 AU2001225380A1 AU2001225380A AU2538001A AU2001225380A1 AU 2001225380 A1 AU2001225380 A1 AU 2001225380A1 AU 2001225380 A AU2001225380 A AU 2001225380A AU 2538001 A AU2538001 A AU 2538001A AU 2001225380 A1 AU2001225380 A1 AU 2001225380A1
- Authority
- AU
- Australia
- Prior art keywords
- reduced
- formula
- sup
- inhibition
- arylalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002532 enzyme inhibitor Substances 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000005018 aryl alkenyl group Chemical group 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004447 heteroarylalkenyl group Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0001572 | 2000-01-24 | ||
| GBGB0001572.7A GB0001572D0 (en) | 2000-01-24 | 2000-01-24 | Inhibitors |
| PCT/GB2001/000171 WO2001053278A1 (en) | 2000-01-24 | 2001-01-17 | 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001225380A1 true AU2001225380A1 (en) | 2001-07-31 |
Family
ID=9884222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001225380A Abandoned AU2001225380A1 (en) | 2000-01-24 | 2001-01-17 | 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6916808B2 (https=) |
| EP (1) | EP1255742B1 (https=) |
| JP (1) | JP2003520278A (https=) |
| AT (1) | ATE417835T1 (https=) |
| AU (1) | AU2001225380A1 (https=) |
| DE (1) | DE60137023D1 (https=) |
| ES (1) | ES2317887T3 (https=) |
| GB (1) | GB0001572D0 (https=) |
| WO (1) | WO2001053278A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2324696C2 (ru) | 2001-08-30 | 2008-05-20 | Ализайм Терапевтикс Лимитед | Тиено-(1,3)-оксазин-4-оны, обладающие ингибирующей активностью по отношению к липазе |
| WO2003053944A1 (en) * | 2001-12-20 | 2003-07-03 | Osi Pharmaceuticals, Inc. | Pancreatic lipase inhibitor compounds, their synthesis and use |
| US8372430B2 (en) | 2002-12-17 | 2013-02-12 | The Procter & Gamble Company | Compositions, methods, and kits useful for the alleviation of gastrointestinal effects |
| WO2006116773A2 (en) * | 2005-04-28 | 2006-11-02 | The Regents Of The University Of California | Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders |
| US9039158B2 (en) * | 2013-06-13 | 2015-05-26 | Xerox Corporation | Ink stick identification system |
| CN111763164B (zh) * | 2019-04-02 | 2023-03-10 | 中国医学科学院药物研究所 | 一类邻位羰基氨基取代苯衍生物的制备方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
| AR022204A1 (es) * | 1999-01-08 | 2002-09-04 | Norgine Bv | Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende. |
-
2000
- 2000-01-24 GB GBGB0001572.7A patent/GB0001572D0/en not_active Ceased
-
2001
- 2001-01-17 US US10/181,868 patent/US6916808B2/en not_active Expired - Fee Related
- 2001-01-17 AT AT01900558T patent/ATE417835T1/de not_active IP Right Cessation
- 2001-01-17 DE DE60137023T patent/DE60137023D1/de not_active Expired - Lifetime
- 2001-01-17 ES ES01900558T patent/ES2317887T3/es not_active Expired - Lifetime
- 2001-01-17 JP JP2001553280A patent/JP2003520278A/ja not_active Withdrawn
- 2001-01-17 EP EP01900558A patent/EP1255742B1/en not_active Expired - Lifetime
- 2001-01-17 WO PCT/GB2001/000171 patent/WO2001053278A1/en not_active Ceased
- 2001-01-17 AU AU2001225380A patent/AU2001225380A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB0001572D0 (en) | 2000-03-15 |
| WO2001053278A1 (en) | 2001-07-26 |
| US20030176429A1 (en) | 2003-09-18 |
| JP2003520278A (ja) | 2003-07-02 |
| EP1255742A1 (en) | 2002-11-13 |
| DE60137023D1 (de) | 2009-01-29 |
| EP1255742B1 (en) | 2008-12-17 |
| ATE417835T1 (de) | 2009-01-15 |
| US6916808B2 (en) | 2005-07-12 |
| ES2317887T3 (es) | 2009-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01006921A (es) | Derivados de 2-oxi-benzoxazinona para el tratamiento de la obesidad. | |
| WO2000040569A8 (en) | 2-amino-benzoxazinone derivatives for the treatment of obesity | |
| EP1090908A3 (en) | Cyclobutane derivatives as inhibitors of protein farnesyltransferase | |
| AU5060490A (en) | 2-(1-piperazinyl)-4-phenylcycloalkano-pyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
| AU5114893A (en) | Novel method of esterification of baccatine iii an 10-deacetylbaccatine iii | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| ES474288A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos | |
| AU2603697A (en) | Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors | |
| AU2001225380A1 (en) | 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors | |
| ATE229526T1 (de) | Pyranone, verfahren zu ihrer herstellung und verwendung | |
| MX9800704A (es) | Esteres y amidas como inhibidores de fosfolipasa a2. | |
| NO20010559L (no) | Fremgangsmate for syntese av (1H)-benzo[c]kinolizin-3-ones derivater | |
| AU1466295A (en) | Amino acid derivatives and their use as phospholipase a2 inhibitors | |
| AU5999798A (en) | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors | |
| AU6731100A (en) | Integrase inhibitors containing aromatic heterocycle derivatives | |
| AU6889096A (en) | Pyrimidine derivatives | |
| Adediran et al. | Synthesis and β-lactamase reactivity of α-substituted phenaceturates | |
| GEP20032928B (en) | Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections | |
| IL151167A0 (en) | Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same | |
| MY139608A (en) | Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity | |
| AU5114993A (en) | Method for the stereoselective preparation of a derivative of beta -phenylisoserine and its use in the preparation of taxane derivatives | |
| DE69608704D1 (de) | Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür | |
| TW200502204A (en) | Oligo acid derivatives | |
| AU1712601A (en) | Novel amidine derivatives, preparation and use thereof as medicines | |
| PT868428E (pt) | Derivados de acido fosfonico possuindo actividade inibidora da metalopeptidase |